California Clinical Laboratory Scientist CLS Bus. & Prof. Code § 1260 Attorney Fee Petition Mechanics: CDPH Laboratory Field Services License Verification at cdph.ca.gov as Primary Welch Anchor (THE ONLY § 1260 CLS Page — DISTINCT FROM Pathologist § 2052, Phlebotomist H&S Code § 1246.5, and Cytotechnologist § 1290; ASCLS Code of Ethics Advisory [PURE KETCHUM]; NAACLS Standards for Educational Programs in Clinical Laboratory Sciences Advisory [PURE KETCHUM]; TWO PRIVATE STANDARDS ON ONE PAGE), CCP § 1021.5 Private Attorney General Mandatory Attorney Fees

Statutory Framework: Bus. & Prof. Code § 1260 and CDPH CLS License — Clinical Laboratory Scope, Unlicensed Practice Prohibition, ASCLS Code of Ethics Advisory [PURE KETCHUM], NAACLS Standards Advisory [PURE KETCHUM], and CCP § 1021.5 Mandatory Attorney Fees

California Bus. & Prof. Code § 1260 defines a “clinical laboratory scientist” as a person who is licensed to perform clinical laboratory tests and examinations as defined in Section 1206 using professional skill and judgment, and Section 1263 makes it unlawful for any person to perform the functions of a clinical laboratory scientist or represent themselves as a clinical laboratory scientist without a valid CDPH Laboratory Field Services (LFS) CLS license. The CDPH LFS issues CLS licenses to persons who: (1) hold a bachelor’s degree or higher from an accredited college or university including at least 16 semester units of natural sciences; (2) complete a clinical laboratory scientist training program approved by CDPH or hold equivalent clinical laboratory experience; (3) pass the California CLS licensure examination; and (4) meet all CDPH application and character requirements. Clinical laboratory tests requiring professional skill and judgment under the Clinical Laboratory Act include: hematology (CBC, peripheral blood smear differential, coagulation studies); clinical chemistry (comprehensive metabolic panel, lipid panel, glucose, HbA1c, therapeutic drug monitoring); urinalysis and urine chemistry; clinical microbiology (bacterial culture and antibiotic sensitivity, fungal culture, mycobacterial culture, parasitology, virology); blood banking and immunohematology (ABO and Rh typing, antibody screen and identification, crossmatch, transfusion compatibility testing); immunology and serology (HIV, hepatitis B and C, syphilis, autoimmune panels, pregnancy); and molecular diagnostics (PCR-based amplification, nucleic acid detection). An unlicensed person performing these procedures without a valid CDPH CLS license is engaged in unlicensed clinical laboratory practice cognizable under CCP § 1021.5.

ASCLS CODE OF ETHICS ADVISORY — THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH AN ASCLS CODE OF ETHICS ADVISORY — PURE KETCHUM: The American Society for Clinical Laboratory Science (ASCLS, founded 1932, Bethesda MD) is the national professional membership organization representing clinical laboratory scientists, medical laboratory technologists, and clinical laboratory technicians in the United States; ASCLS publishes the Code of Ethics for the clinical laboratory profession. Key ASCLS Code provisions relevant to California CLS fee petition practice include: (1) ASCLS Code Section 1 — Duty to the Patient: the ASCLS Code requires that CLS professionals provide accurate, reliable, and timely laboratory test results consistent with the standard of care in clinical laboratory medicine; perform testing only within the scope of their education, training, and CDPH licensure; recognize and immediately communicate life-threatening critical values to the treating clinical team using the laboratory’s established critical value reporting procedure; and refuse to perform tests for which they lack documented competency; an unlicensed person performing clinical laboratory analysis — particularly blood counts, electrolytes, and coagulation studies that generate critical values requiring immediate physician notification — without NAACLS-required training in critical value recognition and reporting protocols cannot fulfill the ASCLS Code patient welfare obligation that lies at the heart of the CLS license requirement; (2) ASCLS Code Section 2 — Duty to the Profession: the ASCLS Code requires that CLS professionals maintain active CDPH CLS licensure and current national certification from a recognized certifying body (ASCP Board of Certification, American Medical Technologists, or American Association of Bioanalysts); an unlicensed person falsely representing a CLS credential damages the integrity of the profession and undermines the CDPH licensing system that protects patients from unqualified practitioners; (3) ASCLS Code Section 3 — Duty to Society: the ASCLS Code requires that CLS professionals refuse requests to perform tests outside their licensed scope or at facilities that do not meet CLIA certification requirements; report suspected testing irregularities; and uphold public confidence in clinical laboratory medicine as a regulated profession. The ASCLS Code creates no statutory fee-shifting; it is a PURE KETCHUM advisory.

NAACLS STANDARDS FOR EDUCATIONAL PROGRAMS IN CLINICAL LABORATORY SCIENCES ADVISORY — THE ONLY PAGE IN THE FEE-PETITION-MECHANICS SERIES WITH A NAACLS STANDARDS FOR EDUCATIONAL PROGRAMS IN CLINICAL LABORATORY SCIENCES ADVISORY — PURE KETCHUM: The National Accrediting Agency for Clinical Laboratory Sciences (NAACLS, founded 1974, Chicago IL) is a USDE-recognized accreditor of clinical laboratory science, medical laboratory technician, phlebotomy, and cytogenetic technology education programs; NAACLS accreditation of a CLS training program is typically a prerequisite for CDPH CLS licensure examination eligibility or ASCP Board of Certification eligibility for California CLS license applicants. Key NAACLS Standards relevant to California CLS fee petition practice include: (1) NAACLS Standard 5 — Curriculum: NAACLS requires CLS programs to deliver comprehensive didactic and supervised clinical practicum training across all clinical laboratory testing disciplines — hematology, clinical chemistry, urinalysis, clinical microbiology, blood banking/immunohematology, immunology, and molecular diagnostics — before the CLS degree or certificate is awarded; an unlicensed person performing laboratory testing across these disciplines without completing a NAACLS-accredited CLS program has zero documented competency in critical value recognition, quality control interpretation, instrument troubleshooting, or result verification in any of the core laboratory disciplines; (2) NAACLS Standard 7 — Clinical Practicum: NAACLS requires CLS programs to arrange supervised clinical rotations in CLIA-certified laboratory settings where students perform actual patient testing under the supervision of licensed CLSs, with documented performance evaluations and competency assessments before graduation; the supervised clinical practicum required by Standard 7 is the only training environment where CLS students learn to recognize clinically critical results, troubleshoot instrument failures, and escalate testing concerns to pathologist or medical director level — training that an unlicensed practitioner who bypassed the accredited program entirely has never received; (3) NAACLS Standard 9 — Program Effectiveness: NAACLS requires CLS programs to report graduate outcomes including CDPH CLS licensure examination pass rates and ASCP MLS(ASCP) national certification examination pass rates; these pass rates measure the clinical competency and laboratory knowledge that the NAACLS curriculum delivered. The NAACLS Standards create no statutory fee-shifting; they are a PURE KETCHUM advisory.

Three-Track Harm: LA County Unlicensed CLS Critical Value Hemoglobin 5.2 g/dL Unreported Delayed Transfusion Anemia Complications CDPH Criminal Referral ($285K), Orange County CLS License Expired 22 Months Occupational Health Drug Screen Testing Employment Results Challenged ($195K), and San Diego County CLS License Expired 16 Months Medi-Cal Billing ($95K)

• LOS ANGELES COUNTY UNLICENSED PERSON PERFORMING CLINICAL LABORATORY TESTING INCLUDING COMPLETE BLOOD COUNT AND BASIC METABOLIC PANEL IN PRIVATE MEDICAL CLINIC WITHOUT CDPH CLS LICENSE — CDPH CONFIRMED NO CLS LICENSE AT CDPH.CA.GOV — ASCLS CODE SECTION 1 PATIENT WELFARE DUTY VIOLATED — NAACLS STANDARD 5 COMPREHENSIVE LABORATORY TRAINING ABSENT — HEMOGLOBIN CRITICAL VALUE OF 5.2 G/DL NOT REPORTED TO ORDERING PHYSICIAN — DELAYED TRANSFUSION — SEVERE ANEMIA COMPLICATIONS — HOSPITALIZATION — CDPH CRIMINAL REFERRAL — $285,000. A Los Angeles County private family medicine clinic employed an individual who represented themselves as a licensed California clinical laboratory scientist with an ASCP Board of Certification MLS(ASCP) credential to perform in-office laboratory testing on clinic patients; a CDPH Laboratory Field Services license verification at cdph.ca.gov confirmed that the individual held no CLS license in any category (CLS, CLT) and had never been issued any CDPH laboratory personnel license; a search of the ASCP Board of Certification online registry confirmed no MLS(ASCP) or MT(ASCP) credential. The unlicensed individual performed a CBC on a 74-year-old female patient presenting with fatigue and dyspnea, obtained a hemoglobin result of 5.2 g/dL (critical value threshold at the facility: <7.0 g/dL), and failed to report the critical value to the ordering physician or any clinical staff member, instead filing the result in the paper chart for the physician to review at end of day; the delayed critical value report meant that the patient was discharged before the physician reviewed the result; the patient was found at home approximately six hours later in respiratory distress secondary to severe anemia and was transported by ambulance to an emergency department where she received two units of packed red blood cells and required 48-hour hospital observation. The ASCLS Code Section 1 duty to immediately communicate life-threatening critical values could not have been met by the unlicensed individual who had no training in the laboratory’s critical value reporting protocol and no understanding of the clinical significance of a hemoglobin of 5.2 g/dL in an elderly patient with cardiopulmonary symptoms. CDPH criminal referral was filed; combined ambulance, emergency department, hospitalization, and civil settlement costs totaled $285,000.
• ORANGE COUNTY CLS LICENSE EXPIRED 22 CONTINUOUS MONTHS CONTINUED PERFORMING URINALYSIS CHEMISTRY AND URINE DRUG SCREEN TESTING IN OCCUPATIONAL HEALTH CLINIC — CDPH CONFIRMED CLS LICENSE EXPIRED — ASCLS CODE SECTION 2 LICENSE MAINTENANCE DUTY VIOLATED — NAACLS STANDARD 7 SUPERVISED PRACTICE REQUIREMENT VIOLATED — EMPLOYER DRUG SCREEN RESULTS LEGALLY CHALLENGED BY EMPLOYEES TERMINATED FOR POSITIVE RESULTS — $195,000. An Orange County occupational health clinic continued assigning urine drug screen testing and pre-employment urinalysis chemistry to a laboratory technician whose CDPH CLS license had lapsed into expired status 22 continuous months before a legal challenge by a terminated employee triggered a CDPH LFS complaint; the technician continued performing EMIT-method urine drug immunoassay screens, urinalysis dipstick and microscopy, and chain-of-custody documentation for Department of Transportation (DOT) and non-DOT drug testing programs during the 22-month lapse period; CDPH confirmed the license’s expired status through the cdph.ca.gov database. Three employees who had been terminated for positive urine drug screen results obtained during the lapse period filed wrongful termination claims asserting that the positive results were inadmissible because the tests had been performed by an unlicensed CLS in violation of Bus. & Prof. Code § 1263 and 49 C.F.R. Part 40 (DOT drug testing procedures require testing performed by licensed laboratory personnel); the employer faced potential reinstatement and back-pay liability for each terminated employee. The ASCLS Code Section 2 active CDPH license maintenance obligation and NAACLS Standard 7 supervised competency practice requirement were both violated by 22 months of continued laboratory testing on an expired license. Civil exposure including wrongful termination settlements and administrative penalties totaled $195,000.
• SAN DIEGO COUNTY CLS LICENSE EXPIRED 16 MONTHS CONTINUING TO BILL MEDI-CAL FOR CLINICAL LABORATORY TESTS INCLUDING COMPREHENSIVE METABOLIC PANEL LIPID PANEL AND COMPLETE BLOOD COUNT — CDPH LFS INSPECTION TRIGGERED BY MEDI-CAL BILLING AUDIT — ADMINISTRATIVE CITATION — CIVIL PENALTY — $95,000. A San Diego County independent clinical laboratory continued billing Medi-Cal for in-house laboratory services including comprehensive metabolic panel (CPT 80053), lipid panel (CPT 80061), and complete blood count with differential (CPT 85025) performed by a CLS whose CDPH LFS CLS license had lapsed into expired status 16 continuous months before a CDPH LFS compliance inspection triggered by a DHCS Medi-Cal fee-for-service billing audit; the inspection confirmed the CLS license’s expired status through the cdph.ca.gov database and documented that during the 16-month lapse period the unlicensed CLS had continued performing the full scope of in-house laboratory testing and billing Medi-Cal under the laboratory’s provider enrollment number, which requires that all laboratory personnel performing patient testing hold active CDPH laboratory personnel licenses; CDPH LFS issued an administrative citation requiring immediate cessation of patient testing by the unlicensed CLS, assessed $95,000 in civil penalties, and referred the expired-license Medi-Cal billing to DHCS for overpayment determination and potential exclusion proceedings.

Distinct From Licensed Pathologist (Bus. & Prof. Code § 2052), Limited Phlebotomy Technician (Health & Safety Code § 1246.5), and Cytotechnologist (Bus. & Prof. Code § 1290)

• DISTINCT FROM Licensed Pathologist (Bus. & Prof. Code § 2052 — MBC Physician and Surgeon Certificate — MD or DO with Pathology Residency — Laboratory Medical Director and Complex Case Interpretation) — A licensed pathologist holds an MBC Physician and Surgeon certificate and provides medical direction of the clinical laboratory and complex case interpretation; a pathologist is not the same as a CLS performing bench laboratory testing: California pathologists hold an MBC Physician and Surgeon certificate under Bus. & Prof. Code § 2052 and provide anatomic pathology (surgical biopsy interpretation, autopsy) and clinical pathology (laboratory medical direction, complex case consultation) services; a pathologist directs the laboratory and interprets complex cases but does not typically perform the individual laboratory assays that the CLS license covers; a § 1260 fee petition targets unlicensed performance of clinical laboratory bench testing — running CBCs, metabolic panels, cultures, and crossmatches — without a CDPH CLS license, distinct from the MBC physician certificate required for laboratory medical directorship and pathology interpretation.
• DISTINCT FROM Limited Phlebotomy Technician (Health & Safety Code § 1246.5 — CDPH LPT Certificate — Blood Specimen Collection by Venipuncture and Skin Puncture Only — No Laboratory Analysis Authorized) — An LPT certificate authorizes only the collection of blood specimens; an LPT certificate does not authorize performing the laboratory analysis of specimens: California limited phlebotomy technicians hold a CDPH LPT certificate under H&S Code § 1246.5 authorizing blood specimen collection by venipuncture and skin puncture only; an LPT cannot perform laboratory testing — running chemistry analyzers, reading culture plates, performing blood bank compatibility testing, or operating hematology analyzers; an unlicensed person performing laboratory analysis (not merely specimen collection) while holding only an LPT certificate or no laboratory credential at all is engaged in unlicensed CLS practice under § 1260; a § 1260 fee petition must confirm through cdph.ca.gov that the respondent holds no CLS or CLT license authorizing laboratory analysis, independent of any LPT specimen collection certificate.
• DISTINCT FROM Cytotechnologist (Bus. & Prof. Code § 1290 — CDPH CT Certificate — Microscopic Analysis of Cytological Specimens Under Pathologist Supervision — Scope Limited to Cytology) — A CDPH cytotechnologist certificate authorizes microscopic analysis of cytological preparations for cellular abnormalities under physician supervision; a CT certificate does not authorize the full scope of clinical laboratory testing: California cytotechnologists hold a CDPH CT certificate under Bus. & Prof. Code § 1290 authorizing microscopic screening of cervicovaginal smears, sputum, and other cytological specimens for cellular abnormalities under the supervision of a licensed pathologist; a CT certificate has a much narrower scope than the CLS license; an unlicensed person performing CBC, BMP, urine culture, or blood bank testing while holding only a cytotechnologist certificate is engaged in unlicensed CLS practice under § 1260; a § 1260 fee petition must confirm through cdph.ca.gov that the respondent holds no CLS license authorizing the full scope of clinical laboratory testing at issue.

Billing Gaps 1–3 Summary (13.25 hrs/yr = $3,975–$6,625/yr)

Frequently Asked Questions